Monocyte-derived macrophages act as reinforcements when microglia fall short in Alzheimer's disease

Miguel A Abellanas1, Maitreyee Purnapatre1, Chiara Burgaletto1

  • 1Department of Brain Sciences, Weizmann Institute of Science, Rehovot, Israel.

Nature Neuroscience
|January 6, 2025
PubMed

Insights

Microglia, the brain's immune cells, can become exhausted during neurological diseases like Alzheimer's. Monocyte-derived macrophages (MDMs) are then needed for repair, but their recruitment is often insufficient.

Area of Science:

  • Neuroimmunology
  • Cellular Biology
  • Neurology

Background:

  • The central nervous system (CNS) contains resident immune cells called microglia, which maintain homeostasis.
  • Microglia act as sentinels but can fail under severe neurological injury or disease.
  • Monocyte-derived macrophages (MDMs) are crucial for repair when microglia are insufficient.

Purpose of the Study:

  • To examine conditions where microglia fail, particularly in Alzheimer's disease.
  • To elucidate the functions of monocyte-derived macrophages (MDMs) in CNS repair.
  • To explore MDM-microglia interactions and strategies to improve MDM recruitment.

Main Methods:

  • Review of existing literature on microglial function and dysfunction.
  • Analysis of cellular mechanisms in neuroinflammation and repair.
  • Discussion of potential therapeutic strategies for enhancing MDM homing.

Main Results:

  • Microglial failure can result from exhaustion or senescence due to prolonged exposure to hostile stimuli.
  • MDMs play a critical role in CNS repair when microglia are compromised.
  • Inadequate MDM recruitment is a significant limitation in neurological disease contexts.

Conclusions:

  • Understanding microglial limitations is key to addressing neurological damage.
  • MDMs offer a potential avenue for therapeutic intervention in CNS diseases.
  • Optimizing MDM recruitment presents a promising strategy for enhancing brain repair.